The global printed electronic materials market is projected to reach $17,559.59 million by 2031 from $3,454.09 million in 2021, growing at a CAGR of 18.82% during the forecast period 2022-2031. North America and China dominated the global printed electronic materials market in 2021. North America, including major countries, such as the U.S., is the most prominent country in the market due to the presence of large automotive and consumer electronics manufacturers.

Market Lifecycle Stage

The printed electronic materials market is in the developing phase. The rising demand for flexible displays along with increasing adoption from new end users such as automotive manufacturers and the consumer electronics industry. The automotive and transportation industry has witnessed an increase in demand for printed electronic materials due to their design flexibility, high performance, and electrophoretic properties.

Impact

Some of the factors behind the expansion of the global printed electronic materials market are increased usage for manufacturing antennas, flexible displays, soft energy devices, sensors, etc. With the rising demand for thinner electronics and wearable devices expanding, the printed electronic materials market is also expected to grow simultaneously. Flexible electronics are involved in today’s cell phones and displays, human and health performance tools, security tags, sensor componentry in cars and airplanes, agricultural and environmental sensors, etc. With the growing adoption of smart devices, the demand for flexible electronics is increasing worldwide, which in turn may result in an increasing demand for printed electronic materials. Further, the recent focus in the medical industry is on the development of smart cards, safe medicine packaging, smart medical wearables, and others. However, higher investment costs are hindering the printed electronic materials market growth.

Impact of COVID-19

The global lockdown due to the COVID-19 epidemic resulted in disruptions in manufacturing activity and supply networks and production halts, all of which had a negative impact on the global printed electronic materials market in 2020. Furthermore, various end-use sectors, such as automotive, consumer electronics, etc., shut down their operations, resulting in lower demand for printed electronic materials in 2020. Furthermore, the printed electronic materials market ended up with faster adoption of challenges faced during the pandemic. The market successfully provided various smart solutions in the healthcare industry, such as the use of printed electronic materials in the manufacturing of printed sensors, smart patient monitoring devices, smart masks, smart patches, etc

Market Segmentation:

Segmentation 1: by Application

• Display
• RFID Tag
• Photovoltaic Cell
• Battery
• Lighting
• Others

Based on applications, the displays segment dominated the printed electronic materials market in 2021 and was the largest segment due to the rising sales of smart devices across the globe. The rising demand for smartphones and flexible electronics devices is leading to the growth of the displays segment as these displays are continuously enhancing the customer experience in consumer electronics, automotive, etc.

Segmentation 2: by End-Use Industry

• Automotive and Transportation
• Consumer Electroncis
• Aerospace and Defense
• Retail and Packaging
• Healthcare
• Others

Based on the end-use industry, the automotive and transportation segment dominated the printed electronic materials market in 2021 and was the largest segment due to the rising sales of electric vehicles across the globe. The rising adoption of electric vehicles is leading to the rise in demand for printed electronic materials for lighting, display, etc.

Segmentation 3: by Material

• Ink
o Silver Ink
o Carbon Ink
o Copper Ink
o Others
• Substrate
o Organic
o Inorganic

The ink segment dominated the printed electronic materials market in 2021 and is the largest segment owing to growing demand from end-use industries such as automotive and consumer electronics due to its lightweight, flexible, thin, and cost-effective nature. In recent times, the demand for carbon-based ink has been increasing and seeking the interests of industrialists, which is helping in the growth of the ink segment in the printed electronic materials market.

Segmentation 4: by Technology

• Inkjet Printing
• Screen Printing
• Gravure Printing
• Flexographic Printing
• Others

Based on technology, the screen printing segment held the majority share in the printed electronic materials market in 2021. It offers the advantage of low-cost equipment providing a large amount of printing at one time and is commonly used for manufacturing membrane keyboards, radio-frequency identification (RFID) antennas, and others.

Segmentation 5: by Region

• North America – U.S., Canada, and Mexico
• Europe – Germany, France, Spain, Italy, and Rest-of-Europe
• China
• U.K.
• Asia-Pacific and Japan – Japan, South Korea, India, Australia, and Rest-of-Asia-Pacific and Japan
• Rest-of-the-World – Middle East and Africa and South America

Among all regions, the North America region dominates the printed electronic materials market as it is the hub for electronics manufacturing and also comprises leading industry players across the supply chain and a fast-developing economy. Moreover, the Asia-Pacific and Japan region is growing with the fastest growth due to rapid industrialization and urbanization.

Recent Developments in the global printed electronic materials market

• In January 2022, Creative Materials developed 129-32 thermoformable in-mold compatible electrically conductive ink, which has applicability in the screen-printing market. The product series has excellent adhesion capabilities to acrylonitrile butadiene styrene (ABS), polyester, poly (methyl methacrylate) (PMMA), polycarbonate (PC), and a variety of other high-energy surfaces.
• In August 2022, C3Nano announced the successful completion of a $35 million growth capital financing by Element Solutions Inc. Furthermore, the received growth capital comprised both equity and debt, enabling the company to expand its Hayward, California-based silver nanowire synthesis and production capacity.

Demand – Drivers and Limitations

The following are the demand drivers for the global printed electronic materials market:

• Growing Adoption of Printed Electronic Materials in the Automotive Industry
• Significant Cost Advantage

The market is expected to face some limitations too due to the following challenge:

• Higher Investment Cost
• Inability to Produce High-Quality Graphene on a Large Scale

How can this report add value to an organization?

Product/Innovation Strategy: The product segment helps the reader understand the different materials, and technologies available for the printed electronic materials market and it’s potential globally. Moreover, the study gives the reader a detailed understanding of the different products with usage in several applications.

Growth/Marketing Strategy: Business expansion, partnership, collaboration, and joint venture are some key strategies adopted by the key players operating in the space; for instance, in July 2022, ACI Materials, Inc. announced a partnership with Sun Nano to enhance its sales network across the globe.

Competitive Strategy: Key players in the printed electronic materials market are analyzed and profiled in the study involving printed electronic materials manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the printed electronic materials market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

Profiled companies have been selected based on inputs gathered from primary experts and analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• Henkel AG & Co. KGaA
• NAGASE & CO., LTD.
• E Ink Holdings Inc.
• Agfa-Gevaert Group
• DuPont de Nemours, Inc.
• BASF SE
• Molex, LLC
• Teikoku Printing Ink Mfg. Co., Ltd.
• Creative Materials
• Poly-ink
• Sun Chemical
• ACI Materials, Inc.
• Kayaku Advanced Materials, Inc.
• C3Nano
• GenesInk
• Dycotec Materials Ltd.
• Copprint
• Mateprincs

The post Printed Electronic Materials Market Report – A Global and Regional Analysis: Focus on Application, End-Use Industry, Material, Technology, and Region – Analysis and Forecast, 2022-2031 first appeared on CRI Report.

Programmed cell death 1 (PD-1) inhibitor and programmed death ligand 1 (PD-L1) inhibitor are therapeutic agents that inhibit binding together of these checkpoint proteins on immune cells, eventually preventing tumors to escape the host immune defense mechanism and control the disease progression. The first PD-1 inhibitor Opdivo developed by Merck Sharp and Dhome (MSD) entered the market in 2014. Jemperli from GSK is the latest market entrant in the segment.

The current market already has seven approved products in the U.S. and a large number of research activities are currently undergoing in this segment generating interest of commercial as well as academic research institutions. In the current period of precision medicine and providing targeted treatment, identification of target patient has become very important as well as complicated. With the emergence of diagnostic test identifying predictive biomarkers, the selection and administration of targeted treatment has become comparativlely conveninent and efficient.

PD-1/PDL-1 inhibitors are majorly indicated for the treatment of advanced cases of different cancer indications. The PD-1/PDL-1 inibitor treatment has been found to be more effective in patients demonstrating certain level of predictive biomarkers such as PDL-1 expression. However, these tests are costly and treatment specific which poses a hinderance to smooth administration of these PD-1/PDL-1 inhibitors to larger set of patients.

Several players, such as MSD, Bristol Myers Squibb company (BMS), AstraZeneca Plc are among the leading companies actively pursuing research activities in maximizing the potential of PD-1/PDL-1 inhbitors. Companies in the Asia-Pacific region also have rich clinical pipeline and strategically pursuing research activities in this segment.

 Competitive Landscape

There are seven product currently available in the market. The first entrant Keytruda drwas a significant share of the market followed by second entrant Opdivo. Imfinzi and Tecentriq also have their combined market share below 20%.

Disease Landscape

In terms of most promising indication for the application of PD-1/PDL-1 inhibitors, melanoma appears to be leading as highlighted by experts including data gathered from secondary research.

Segmentation:

Within the research report, the segmentation has made on the basis of:

• Identified cancer indicattions (Non-small cell lung cancer, melanoma, breast cancer, hepatocellular carcinoma, colorectal cancer, and urothelial carcinoma), and
• The seven major markets (the U.S., the U.K., Germany, France, Italy, Spain, and Japan).

This segmentation highlights value propositions and business models useful for industry leaders and stakeholders. The research also comprises country-level analysis, go-to-market strategies of leading players, and future opportunities, among others, to detail the scope and provide a 360-coverage of the domain.

Demand – Drivers and Challenges

Some of the potential drivers includes:

• Increased Use of PD-1/PDL-1 Inhibitors in Multiple Sub-set of Cancer Indications
• Increase in PD-1/PDL-1 Inhibitor Based Combination Regimens

The market is expected to face some limitations too due to the following challenges:

• Immune-related Adverse Events Associated With PD-1/PDL-1 Inhibitor Treatment are a Cause of Concern
• Treatment Specific Biomarkers Assays Pose Hinderance to Smooth Adoption of PD-1/PDL-1 Inhibitor Treatment

How can this report add value to an organization?

Product/Innovation Strategy: The report provides an exhaustive list of pipeline products which are currently in the development along with their developmental details in various indications. This can help organizations in understanding the research activities, which is the promising indication to pursue or which organization has the potential product to enter first into the market as well it can help the organization to assess where should they place themselves in order to get maximum benefit. This report which provides an insight into estimated patient population eligible to receive PD-1/PDL-1 under identified indications will help to evaluate the promising indications.

Growth/Marketing Strategy: In addition to pursuing research on exploring the benefits of PD-1/PDL-1 inhibitors in multiple cancer indications, companies are working to bring more safer and convenient PD-1/PDL-1 inhbitors while retaining or improved efficacy. The companies are exploring small molecules as well as alternative formulations for PD-1/PDL-1 inhibitors in an effort to make the administration relatively more convenient.

Competitive Strategy: Key players in the global PD-1/PDL-1 inhibitor market were analyzed and profiled in the study, who have commercially available PD-1/PDL-1 inhbitors as well as those who are developing and their products are in the clinical development. Moreover, a detailed competitive benchmarking of the players operating in the global PD-1/PDL-1 inhibitor market has been done to help the reader understand how players stand against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Companies Profiled

• GlaxoSmithKline plc
• Bristol-Myers Squibb Company
• Arcus Biosciences, Inc.
• Agenus Inc.
• F. Hoffmann-La Roche Ltd
• Astra Zeneca PLC
• Beigene Ltd.
• Shanghai Junshi Bioscience Co. Ltd.
• Shanghai Henlius Biotech, Inc.
• Jiangsu HengRui Medicine Co., Ltd.
• Lee’s Pharmaceutical Limited
• Incyte Corporation
• Biocad
• CStone Pharmaceuticals

The post PD-1/PDL-1 Inhibitor Market – A Global and Regional Analysis: Focus on Epidemiology, Product, and Region – Analysis and Forecast, 2022-2032 first appeared on CRI Report.